Heron Therapeutics (HRTX) Plans Common Stock Offering

Heron Therapeutics (NASDAQ: HRTX) announced its intention to offer and sell shares of its common stock in an underwritten offering pursuant to existing shelf registrations. All of the shares in the proposed offering are to be sold by Heron Therapeutics, Inc.

Jefferies LLC, Leerink Partners LLC and Cowen and Company, LLC are acting as joint book-runners for the offering. Heron Therapeutics, Inc. intends to grant the underwriters a 30-day option to purchase additional shares of its common stock. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.

You May Also Be Interested In

• Avere Therapeutics raises $500M in private placement for drug program
• TD Cowen Downgrades Inter Parfums (IPAR) to Hold
• Innovate to sell DBM Global to IES Holdings for $650 million